EAS Congress

In 2027, we meet in Gothenburg, Sweden! Join us at the 95th EAS Congress from 30 May - 2 June 2027 for more science, collaboration, and discussion across atherosclerosis and cardiovascular medicine. 🔗 bit.ly/4eKgl96 #EASCongress2027 #CardiovascularResearch

A reminder for all #EASCongress2026 participants - your 15.0 ECMEC®s are waiting to be claimed! The process takes around 5 minutes and your feedback plays an important role in improving future EAS educational activities. 🔗 bit.ly/4wp2sU4 #CardiovascularHealth

Some congress moments stay with you. Presenting my SaaG poster at #EASCongress2026 on the intersection between reproductive planning and lipid management, and discussing it with Marianne Benn as moderator, was one of them. A real honour, and a very thoughtful exchange #MyEAS2026

Very glad to 🗣️ Nick Nurmohamed’s work on inflam plaques during the EAS Research Grant Winners session. The question is no longer whether inflam matters in ath, but how we identify biologically active plaques and translate that into better clinical decisions. Great work, Nick! 👏

The real value of a programme like this is not only what it gives you during the fellowship. It is what stays afterwards: a network, a sense of belonging, and the confidence to take your place in the scientific conversation #EASCongress2026 #MyEAS2026

That is why I was very happy to speak about the EAS Young Fellows Programme at #EASCongress2026. For me, it has been much more than a fellowship: a place where ideas are challenged, collaborations start, and young researchers learn to contribute with confidence #MyEAS2026

My take 🏡 from the EAS Stage: Social media is not the opposite of serious medicine. Used responsibly, it helps scientific societies enter the space where opinions, doubts and decisions are formed. That is not marketing. That is prevention #EASCongress2026 #MyEAS2026 @society_eas

In prevention, the weakest point is often the drop off. Risk is identified, but the patient does not reach treatment. Treatment is started, but not intensified. Therapy is prescribed, but trust is missing. SAFE HEARTS needs to protect the whole chain #EASCongress2026 @society_eas

This year's @EASCongress #2026 was phenomenal. Congratulations to @BNordestgaard, @ProfKausikRay and the whole team! ⚡ The Anistschkow Prize 2026 winner Prof Heribert Shunkert shared his decades of groundbreaking work in opening talk on "Interplay of #genetics and modifiable risk in #atherosclerosis" ⚡ Joint sessions of @nationallipid - #EAS and @escardio -#EAS were packed to capacity. ⚡ Best part, I got to meet and learn from my friends and thought leaders from around the world! @drpablocorral @ErinMichos @DineshKalra @FedericaFogacci @skathire @CBallantyneMD @society_eas See you all next year in #Gothenburg!

The future #EASCongress2026 ANGPTL3 silencing is entering a very interesting space in lipid lowering. Preclinical and Phase 1 data on AZD1705, a liver targeted approach aiming to lower atherogenic lipoproteins

#EASCongress2026 and #Atherosclerosis

And just like that #EASCongress2026 has come to an end! Thank you to everyone who joined us for plenaries, workshops, scientific discussions, poster sessions, networking, and shared moments across the congress. Remember to claim your credits 🔗 bit.ly/4wp2sU4 #Athens

Thousands of steps, busy congress days, and one top stepper! 👏 Congratulations to Lisaidy Ramos Regalado, winner of the EAS Step Competition! Thank you to everyone who joined the challenge and stayed active throughout the congress in Athens. #EASCongress2026 #Athens

Day 4 EAS Scavenger hunt winner is Beatriz Miranda! Congratulations 🎉 One last prize is on the lookout - who will be our last winner? #EASCongress2026 #Atherosclerosis

Final Late Breaker session of #EASCongress2026 starts at 10:30 in Aravanis Hall! Join experts presenting new research on vascular inflammation, clonal haematopoiesis, smooth muscle cell foam cells, myelopoiesis, and lipid metabolism in atherosclerosis. #Atherosclerosis

Three parallel workshops open at 10:30 today across Anitschkow, Nana, and Elisaf halls - from genetic dyslipidemias to immune cell pathways and ASCVD detection. 🔗 bit.ly/4kUrSDW #EASCongress2026 #Atherosclerosis

Wonderful experience at #MyEAS2026 connecting with great leaders of the field and amazing people, top notch science in the beautiful city of Athens. Thank you for the memories @EASCongress @EugeniaGianos @iuliaiatan @ErinMichos @marstonMD Next up the #NLASessions2026 in Chicago. See you all there for more groundbreaking lipid science @nationallipid

From vulnerable plaque to vulnerable patient. Isabel Gonçalves’ 🆕 @ATHjournal review asks whether imaging + circulating markers can predict plaque vulnerability. Catch her #EASCongress2026 plenary: 🕘 09:14 | Anitschkow Hall 🔗 atherosclerosis-journal.com/article/S0021-… @EASCongress @society_eas

@society_eas @EASCongress Take-home from this keynote: ApoB is becoming more than a “better LDL marker”. It is a framework to integrate particle number, particle type, atherogenicity and biology. ApoB 2026 is not only answers. It is better questions. #EASCongress2026 #MyEAS2026

Last opportunity to participate in the EAS Photo Contest! From sessions to meetings to Athens itself, capture your congress experience and post with #MyEAS2026 before 12:30 EEST. 🔗 bit.ly/4fjAEKF #EASCongress2026 #Athens